Annual CFI
-$43.28 M
-$21.51 M-98.79%
December 31, 2023
Summary
- As of February 8, 2025, ANTX annual cash flow from investing activities is -$43.28 million, with the most recent change of -$21.51 million (-98.79%) on December 31, 2023.
- During the last 3 years, ANTX annual CFI has fallen by -$43.28 million (-100.00%).
Performance
ANTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$18.72 M
+$2.26 M+13.72%
September 30, 2024
Summary
- As of February 8, 2025, ANTX quarterly cash flow from investing activities is $18.72 million, with the most recent change of +$2.26 million (+13.72%) on September 30, 2024.
- Over the past year, ANTX quarterly CFI has dropped by -$7.57 million (-28.80%).
- ANTX quarterly CFI is now -28.80% below its all-time high of $26.29 million, reached on March 31, 2024.
Performance
ANTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$61.89 M
+$81.18 M+420.80%
September 30, 2024
Summary
- As of February 8, 2025, ANTX TTM cash flow from investing activities is $61.89 million, with the most recent change of +$81.18 million (+420.80%) on September 30, 2024.
- Over the past year, ANTX TTM CFI has increased by +$89.76 million (+322.02%).
- ANTX TTM CFI is now at all-time high.
Performance
ANTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ANTX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -98.8% | -28.8% | +322.0% |
| 3 y3 years | -100.0% | -28.8% | +322.0% |
| 5 y5 years | -100.0% | -28.8% | +322.0% |
ANTX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.8% | +13.5% | -28.8% | +130.0% | at high | +223.7% |
| 5 y | 5-year | <-9999.0% | +13.5% | -28.8% | +130.0% | at high | +210.0% |
| alltime | all time | <-9999.0% | +13.5% | -28.8% | +130.0% | at high | +210.0% |
AN2 Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $18.72 M(+13.7%) | $61.89 M(-420.8%) |
| Jun 2024 | - | $16.46 M(-37.4%) | -$19.29 M(-30.8%) |
| Mar 2024 | - | $26.29 M(+6159.5%) | -$27.88 M(-35.6%) |
| Dec 2023 | -$43.28 M(+98.8%) | $420.00 K(-100.7%) | -$43.28 M(+15.0%) |
| Sep 2023 | - | -$62.46 M(-893.0%) | -$37.64 M(-267.3%) |
| Jun 2023 | - | $7.88 M(-27.6%) | $22.50 M(-190.5%) |
| Mar 2023 | - | $10.89 M(+79.8%) | -$24.86 M(+14.2%) |
| Dec 2022 | -$21.77 M | $6.05 M(-361.3%) | -$21.77 M(+0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$2.32 M(-94.1%) | -$21.58 M(-17.8%) |
| Jun 2022 | - | -$39.49 M(-382.5%) | -$26.25 M(-27.2%) |
| Mar 2022 | - | $13.98 M(+123.8%) | -$36.05 M(-27.9%) |
| Dec 2021 | -$50.02 M(<-9900.0%) | - | - |
| Dec 2021 | - | $6.25 M(-189.4%) | -$50.02 M(-11.1%) |
| Sep 2021 | - | -$6.99 M(-85.8%) | -$56.27 M(+14.2%) |
| Jun 2021 | - | -$49.28 M(<-9900.0%) | -$49.28 M(<-9900.0%) |
| Mar 2021 | - | $0.00 | $0.00 |
| Dec 2020 | $0.00 | - | - |
FAQ
- What is AN2 Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for AN2 Therapeutics?
- What is AN2 Therapeutics annual CFI year-on-year change?
- What is AN2 Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for AN2 Therapeutics?
- What is AN2 Therapeutics quarterly CFI year-on-year change?
- What is AN2 Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for AN2 Therapeutics?
- What is AN2 Therapeutics TTM CFI year-on-year change?
What is AN2 Therapeutics annual cash flow from investing activities?
The current annual CFI of ANTX is -$43.28 M
What is the all time high annual CFI for AN2 Therapeutics?
AN2 Therapeutics all-time high annual cash flow from investing activities is $0.00
What is AN2 Therapeutics annual CFI year-on-year change?
Over the past year, ANTX annual cash flow from investing activities has changed by -$21.51 M (-98.79%)
What is AN2 Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ANTX is $18.72 M
What is the all time high quarterly CFI for AN2 Therapeutics?
AN2 Therapeutics all-time high quarterly cash flow from investing activities is $26.29 M
What is AN2 Therapeutics quarterly CFI year-on-year change?
Over the past year, ANTX quarterly cash flow from investing activities has changed by -$7.57 M (-28.80%)
What is AN2 Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ANTX is $61.89 M
What is the all time high TTM CFI for AN2 Therapeutics?
AN2 Therapeutics all-time high TTM cash flow from investing activities is $61.89 M
What is AN2 Therapeutics TTM CFI year-on-year change?
Over the past year, ANTX TTM cash flow from investing activities has changed by +$89.76 M (+322.02%)